Report Detail

Request for Sample of this report

Pharma & Healthcare Global Orally Disintegrating Films (ODFs) Market Research Report 2022

  • RnM4430617
    • |
  • 02 May, 2022
    • |
  • Global
    • |
  • 107 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Summary:

Orally disintegrating films can be produced with different polymers, which is the main responsible for properties such as disintegration time and mucoadhesiveness, aiming at controlled and more effective release of the active compounds.
Industry Insights
Due to the COVID-19 pandemic, the global Orally Disintegrating Films (ODFs) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Orally Disintegrating Films (ODFs) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Orally Disintegrating Films (ODFs) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Orodispersible Film accounting for % of the Orally Disintegrating Films (ODFs) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital and Clinic segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Orally Disintegrating Films (ODFs) include Aquestive Therapeutics, Kyukyu Pharmaceutical, BioDelivery(BDSI), IntelGenx, Tapemark, Shilpa Therapeutics, CL Pharm, Lubrizol Life Science and Adhex Pharma, etc. In terms of revenue, the global 3 largest players have a % market share of Orally Disintegrating Films (ODFs) in 2021.
This report focuses on Orally Disintegrating Films (ODFs) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Orally Disintegrating Films (ODFs) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and India, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Orally Disintegrating Films (ODFs) market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
Orodispersible Film
Oromucosal Film
Segment by Application
Hospital and Clinic
Drug Store
E-commerce
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Aquestive Therapeutics
Kyukyu Pharmaceutical
BioDelivery(BDSI)
IntelGenx
Tapemark
Shilpa Therapeutics
CL Pharm
Lubrizol Life Science
Adhex Pharma
DK Livkon
Arx Pharma
Aavishkar
ZIM Laboratories
Umang Pharmaceuticals
Cure Pharmaceutical
Frequently Asked Questions
Which product segment grabbed the largest share in the Orally Disintegrating Films (ODFs) market?
How is the competitive scenario of the Orally Disintegrating Films (ODFs) market?
Which are the key factors aiding the Orally Disintegrating Films (ODFs) market growth?
Which are the prominent players in the Orally Disintegrating Films (ODFs) market?
Which region holds the maximum share in the Orally Disintegrating Films (ODFs) market?
What will be the CAGR of the Orally Disintegrating Films (ODFs) market during the forecast period?
Which application segment emerged as the leading segment in the Orally Disintegrating Films (ODFs) market?
What key trends are likely to emerge in the Orally Disintegrating Films (ODFs) market in the coming years?
What will be the Orally Disintegrating Films (ODFs) market size by 2028?
Which company held the largest share in the Orally Disintegrating Films (ODFs) market?


Table of Contents

    1 Orally Disintegrating Films (ODFs) Market Overview

    • 1.1 Product Overview and Scope of Orally Disintegrating Films (ODFs)
    • 1.2 Orally Disintegrating Films (ODFs) Segment by Type
      • 1.2.1 Global Orally Disintegrating Films (ODFs) Sales Growth Rate Comparison by Type (2022-2028)
      • 1.2.2 Orodispersible Film
      • 1.2.3 Oromucosal Film
    • 1.3 Orally Disintegrating Films (ODFs) Segment by Application
      • 1.3.1 Global Orally Disintegrating Films (ODFs) Sales Comparison by Application: (2022-2028)
      • 1.3.2 Hospital and Clinic
      • 1.3.3 Drug Store
      • 1.3.4 E-commerce
    • 1.4 Global Orally Disintegrating Films (ODFs) Market Size Estimates and Forecasts
      • 1.4.1 Global Orally Disintegrating Films (ODFs) Revenue 2017-2028
      • 1.4.2 Global Orally Disintegrating Films (ODFs) Sales 2017-2028
      • 1.4.3 Orally Disintegrating Films (ODFs) Market Size by Region: 2017 Versus 2021 Versus 2028

    2 Orally Disintegrating Films (ODFs) Market Competition by Manufacturers

    • 2.1 Global Orally Disintegrating Films (ODFs) Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Orally Disintegrating Films (ODFs) Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Orally Disintegrating Films (ODFs) Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Orally Disintegrating Films (ODFs) Manufacturing Sites, Area Served, Product Type
    • 2.5 Orally Disintegrating Films (ODFs) Market Competitive Situation and Trends
      • 2.5.1 Orally Disintegrating Films (ODFs) Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest Orally Disintegrating Films (ODFs) Players Market Share by Revenue
      • 2.5.3 Global Orally Disintegrating Films (ODFs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 Orally Disintegrating Films (ODFs) Retrospective Market Scenario by Region

    • 3.1 Global Orally Disintegrating Films (ODFs) Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Orally Disintegrating Films (ODFs) Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Orally Disintegrating Films (ODFs) Market Facts & Figures by Country
      • 3.3.1 North America Orally Disintegrating Films (ODFs) Sales by Country
      • 3.3.2 North America Orally Disintegrating Films (ODFs) Revenue by Country
      • 3.3.3 United States
      • 3.3.4 Canada
    • 3.4 Europe Orally Disintegrating Films (ODFs) Market Facts & Figures by Country
      • 3.4.1 Europe Orally Disintegrating Films (ODFs) Sales by Country
      • 3.4.2 Europe Orally Disintegrating Films (ODFs) Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Orally Disintegrating Films (ODFs) Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Orally Disintegrating Films (ODFs) Sales by Region
      • 3.5.2 Asia Pacific Orally Disintegrating Films (ODFs) Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 China Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
    • 3.6 Latin America Orally Disintegrating Films (ODFs) Market Facts & Figures by Country
      • 3.6.1 Latin America Orally Disintegrating Films (ODFs) Sales by Country
      • 3.6.2 Latin America Orally Disintegrating Films (ODFs) Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
    • 3.7 Middle East and Africa Orally Disintegrating Films (ODFs) Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Orally Disintegrating Films (ODFs) Sales by Country
      • 3.7.2 Middle East and Africa Orally Disintegrating Films (ODFs) Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Global Orally Disintegrating Films (ODFs) Historic Market Analysis by Type

    • 4.1 Global Orally Disintegrating Films (ODFs) Sales Market Share by Type (2017-2022)
    • 4.2 Global Orally Disintegrating Films (ODFs) Revenue Market Share by Type (2017-2022)
    • 4.3 Global Orally Disintegrating Films (ODFs) Price by Type (2017-2022)

    5 Global Orally Disintegrating Films (ODFs) Historic Market Analysis by Application

    • 5.1 Global Orally Disintegrating Films (ODFs) Sales Market Share by Application (2017-2022)
    • 5.2 Global Orally Disintegrating Films (ODFs) Revenue Market Share by Application (2017-2022)
    • 5.3 Global Orally Disintegrating Films (ODFs) Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Aquestive Therapeutics
      • 6.1.1 Aquestive Therapeutics Corporation Information
      • 6.1.2 Aquestive Therapeutics Description and Business Overview
      • 6.1.3 Aquestive Therapeutics Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.1.4 Aquestive Therapeutics Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.1.5 Aquestive Therapeutics Recent Developments/Updates
    • 6.2 Kyukyu Pharmaceutical
      • 6.2.1 Kyukyu Pharmaceutical Corporation Information
      • 6.2.2 Kyukyu Pharmaceutical Description and Business Overview
      • 6.2.3 Kyukyu Pharmaceutical Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.2.4 Kyukyu Pharmaceutical Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.2.5 Kyukyu Pharmaceutical Recent Developments/Updates
    • 6.3 BioDelivery(BDSI)
      • 6.3.1 BioDelivery(BDSI) Corporation Information
      • 6.3.2 BioDelivery(BDSI) Description and Business Overview
      • 6.3.3 BioDelivery(BDSI) Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.3.4 BioDelivery(BDSI) Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.3.5 BioDelivery(BDSI) Recent Developments/Updates
    • 6.4 IntelGenx
      • 6.4.1 IntelGenx Corporation Information
      • 6.4.2 IntelGenx Description and Business Overview
      • 6.4.3 IntelGenx Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 IntelGenx Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.4.5 IntelGenx Recent Developments/Updates
    • 6.5 Tapemark
      • 6.5.1 Tapemark Corporation Information
      • 6.5.2 Tapemark Description and Business Overview
      • 6.5.3 Tapemark Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.5.4 Tapemark Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.5.5 Tapemark Recent Developments/Updates
    • 6.6 Shilpa Therapeutics
      • 6.6.1 Shilpa Therapeutics Corporation Information
      • 6.6.2 Shilpa Therapeutics Description and Business Overview
      • 6.6.3 Shilpa Therapeutics Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.6.4 Shilpa Therapeutics Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.6.5 Shilpa Therapeutics Recent Developments/Updates
    • 6.7 CL Pharm
      • 6.6.1 CL Pharm Corporation Information
      • 6.6.2 CL Pharm Description and Business Overview
      • 6.6.3 CL Pharm Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 CL Pharm Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.7.5 CL Pharm Recent Developments/Updates
    • 6.8 Lubrizol Life Science
      • 6.8.1 Lubrizol Life Science Corporation Information
      • 6.8.2 Lubrizol Life Science Description and Business Overview
      • 6.8.3 Lubrizol Life Science Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.8.4 Lubrizol Life Science Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.8.5 Lubrizol Life Science Recent Developments/Updates
    • 6.9 Adhex Pharma
      • 6.9.1 Adhex Pharma Corporation Information
      • 6.9.2 Adhex Pharma Description and Business Overview
      • 6.9.3 Adhex Pharma Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.9.4 Adhex Pharma Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.9.5 Adhex Pharma Recent Developments/Updates
    • 6.10 DK Livkon
      • 6.10.1 DK Livkon Corporation Information
      • 6.10.2 DK Livkon Description and Business Overview
      • 6.10.3 DK Livkon Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.10.4 DK Livkon Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.10.5 DK Livkon Recent Developments/Updates
    • 6.11 Arx Pharma
      • 6.11.1 Arx Pharma Corporation Information
      • 6.11.2 Arx Pharma Orally Disintegrating Films (ODFs) Description and Business Overview
      • 6.11.3 Arx Pharma Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.11.4 Arx Pharma Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.11.5 Arx Pharma Recent Developments/Updates
    • 6.12 Aavishkar
      • 6.12.1 Aavishkar Corporation Information
      • 6.12.2 Aavishkar Orally Disintegrating Films (ODFs) Description and Business Overview
      • 6.12.3 Aavishkar Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.12.4 Aavishkar Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.12.5 Aavishkar Recent Developments/Updates
    • 6.13 ZIM Laboratories
      • 6.13.1 ZIM Laboratories Corporation Information
      • 6.13.2 ZIM Laboratories Orally Disintegrating Films (ODFs) Description and Business Overview
      • 6.13.3 ZIM Laboratories Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.13.4 ZIM Laboratories Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.13.5 ZIM Laboratories Recent Developments/Updates
    • 6.14 Umang Pharmaceuticals
      • 6.14.1 Umang Pharmaceuticals Corporation Information
      • 6.14.2 Umang Pharmaceuticals Orally Disintegrating Films (ODFs) Description and Business Overview
      • 6.14.3 Umang Pharmaceuticals Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.14.4 Umang Pharmaceuticals Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.14.5 Umang Pharmaceuticals Recent Developments/Updates
    • 6.15 Cure Pharmaceutical
      • 6.15.1 Cure Pharmaceutical Corporation Information
      • 6.15.2 Cure Pharmaceutical Orally Disintegrating Films (ODFs) Description and Business Overview
      • 6.15.3 Cure Pharmaceutical Orally Disintegrating Films (ODFs) Sales, Revenue and Gross Margin (2017-2022)
      • 6.15.4 Cure Pharmaceutical Orally Disintegrating Films (ODFs) Product Portfolio
      • 6.15.5 Cure Pharmaceutical Recent Developments/Updates

    7 Orally Disintegrating Films (ODFs) Manufacturing Cost Analysis

    • 7.1 Orally Disintegrating Films (ODFs) Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Orally Disintegrating Films (ODFs)
    • 7.4 Orally Disintegrating Films (ODFs) Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Orally Disintegrating Films (ODFs) Distributors List
    • 8.3 Orally Disintegrating Films (ODFs) Customers

    9 Orally Disintegrating Films (ODFs) Market Dynamics

    • 9.1 Orally Disintegrating Films (ODFs) Industry Trends
    • 9.2 Orally Disintegrating Films (ODFs) Market Drivers
    • 9.3 Orally Disintegrating Films (ODFs) Market Challenges
    • 9.4 Orally Disintegrating Films (ODFs) Market Restraints

    10 Global Market Forecast

    • 10.1 Orally Disintegrating Films (ODFs) Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Orally Disintegrating Films (ODFs) by Type (2023-2028)
      • 10.1.2 Global Forecasted Revenue of Orally Disintegrating Films (ODFs) by Type (2023-2028)
    • 10.2 Orally Disintegrating Films (ODFs) Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Orally Disintegrating Films (ODFs) by Application (2023-2028)
      • 10.2.2 Global Forecasted Revenue of Orally Disintegrating Films (ODFs) by Application (2023-2028)
    • 10.3 Orally Disintegrating Films (ODFs) Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Orally Disintegrating Films (ODFs) by Region (2023-2028)
      • 10.3.2 Global Forecasted Revenue of Orally Disintegrating Films (ODFs) by Region (2023-2028)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:
      Get latest Market Research Reports on Orally Disintegrating Films (ODFs). Industry analysis & Market Report on Orally Disintegrating Films (ODFs) is a syndicated market report, published as Global Orally Disintegrating Films (ODFs) Market Research Report 2022. It is complete Research Study and Industry Analysis of Orally Disintegrating Films (ODFs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$2,900.00
      		$5,800.00
      		2,241.70
      		4,483.40
      		2,673.80
      		5,347.60
      		443,004.00
      		886,008.00
      		243,919.00
      		487,838.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo